Molecular therapies for fibrolamellar carcinoma (FLC)
Timeframe: 2019 – date Goal: Investigate the potential of heat shock protein 70 (Hsp70) and mitogen-activated protein kinases (MAPKs) as therapeutic options for FLC Principal Investigator: John Scott, PhD, Edwin G. Krebs-Speights Professor of Cell Signaling and Cancer Biology, and Chair, Department of Pharmacology Precision medicine approaches have identified the underlying genetic defect in FLC …